ANI Pharmaceuticals (ANIP) Competitors

ANI Pharmaceuticals (NASDAQ:ANIP) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Which has more risk and volatility, ANIP or TGTX?

ANI Pharmaceuticals has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.24, suggesting that its stock price is 124% more volatile than the S&P 500.

Does the MarketBeat Community prefer ANIP or TGTX?

TG Therapeutics received 224 more outperform votes than ANI Pharmaceuticals when rated by MarketBeat users. Likewise, 76.42% of users gave TG Therapeutics an outperform vote while only 64.58% of users gave ANI Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
ANI Pharmaceuticals	Outperform Votes 434 64.58%	Underperform Votes 238 35.42%
TG Therapeutics	Outperform Votes 658 76.42%	Underperform Votes 203 23.58%

Is ANIP or TGTX more profitable?

ANI Pharmaceuticals has a net margin of -1.28% compared to TG Therapeutics' net margin of -5.42%. ANI Pharmaceuticals' return on equity of 15.87% beat TG Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANI Pharmaceuticals	-1.28%	15.87%	6.88%
TG Therapeutics	-5.42%	-8.32%	-3.40%

Do insiders and institutionals hold more shares of ANIP or TGTX?

76.1% of ANI Pharmaceuticals shares are owned by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are owned by institutional investors. 12.7% of ANI Pharmaceuticals shares are owned by insiders. Comparatively, 10.5% of TG Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Does the media prefer ANIP or TGTX?

In the previous week, TG Therapeutics had 10 more articles in the media than ANI Pharmaceuticals. MarketBeat recorded 16 mentions for TG Therapeutics and 6 mentions for ANI Pharmaceuticals. TG Therapeutics' average media sentiment score of 0.99 beat ANI Pharmaceuticals' score of 0.91 indicating that TG Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ANI Pharmaceuticals	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TG Therapeutics	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer ANIP or TGTX?

ANI Pharmaceuticals presently has a consensus target price of $77.71, indicating a potential upside of 33.62%. TG Therapeutics has a consensus target price of $40.67, indicating a potential upside of 39.56%. Given TG Therapeutics' higher possible upside, analysts clearly believe TG Therapeutics is more favorable than ANI Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ANI Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.00
TG Therapeutics	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Which has better earnings & valuation, ANIP or TGTX?

ANI Pharmaceuticals has higher revenue and earnings than TG Therapeutics. TG Therapeutics is trading at a lower price-to-earnings ratio than ANI Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANI Pharmaceuticals	$486.82M	2.51	$18.78M	-$0.55	-105.75
TG Therapeutics	$233.66M	19.41	$12.67M	-$0.10	-291.37

Summary

ANI Pharmaceuticals beats TG Therapeutics on 11 of the 19 factors compared between the two stocks.